Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019

Coronavirus disease 2019 is a major threat to public health globally. Though its pathogenesis has not been fully elucidated, angiotensin-converting enzyme 2 (ACE2) has been recently identified as a receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the cell....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meng-Yuan Liu, Bo Zheng, Yan Zhang, Jian-Ping Li
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2020
Materias:
Acceso en línea:https://doaj.org/article/206b816da909444199c0f4f7c34d5205
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:206b816da909444199c0f4f7c34d5205
record_format dspace
spelling oai:doaj.org-article:206b816da909444199c0f4f7c34d52052021-12-02T16:02:19ZRole and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 20192095-882X10.1016/j.cdtm.2020.05.003https://doaj.org/article/206b816da909444199c0f4f7c34d52052020-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095882X20300426https://doaj.org/toc/2095-882XCoronavirus disease 2019 is a major threat to public health globally. Though its pathogenesis has not been fully elucidated, angiotensin-converting enzyme 2 (ACE2) has been recently identified as a receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the cell. Here, we aimed to clarify the potential role of ACE2 in SARS-CoV-2-induced acute lung injury and its underlying mechanism. As a receptor for coronavirus, ACE2 mediates the entry of SARS-CoV-2 into cells in a similar way as for severe acute respiratory syndrome coronavirus (SARS-CoV). The high binding affinity of SARS-CoV-2 to ACE2 correlates with its efficient spread among humans. On the other hand, ACE2 negatively regulates the renin-angiotensin-aldosterone system (RAAS) primarily by converting angiotensin II to angiotensin 1–7, which exerts a beneficial effect on coronavirus-induced acute lung injury. Human recombinant ACE2 has been considered as a potential therapy for SARS-CoV-2 by blocking virus entry and redressing the imbalance of RAAS in SARS-CoV-2 infection. The level of ACE2 expression can be upregulated by treatment with an ACE inhibitor (ACEI) or angiotensin Ⅱ type 1 receptor blocker (ARB). To date, no evidence shows that ACEIs or ARBs increase the susceptibility and mortality of patients infected with SARS-CoV-2, and hence, it is not advisable to discontinue such drugs in patients with cardiovascular disease.Meng-Yuan LiuBo ZhengYan ZhangJian-Ping LiKeAi Communications Co., Ltd.articleSevere acute respiratory syndrome coronavirus 2Angiotensin-converting enzyme 2Acute lung injuryMedicine (General)R5-920ENChronic Diseases and Translational Medicine, Vol 6, Iss 2, Pp 98-105 (2020)
institution DOAJ
collection DOAJ
language EN
topic Severe acute respiratory syndrome coronavirus 2
Angiotensin-converting enzyme 2
Acute lung injury
Medicine (General)
R5-920
spellingShingle Severe acute respiratory syndrome coronavirus 2
Angiotensin-converting enzyme 2
Acute lung injury
Medicine (General)
R5-920
Meng-Yuan Liu
Bo Zheng
Yan Zhang
Jian-Ping Li
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
description Coronavirus disease 2019 is a major threat to public health globally. Though its pathogenesis has not been fully elucidated, angiotensin-converting enzyme 2 (ACE2) has been recently identified as a receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the cell. Here, we aimed to clarify the potential role of ACE2 in SARS-CoV-2-induced acute lung injury and its underlying mechanism. As a receptor for coronavirus, ACE2 mediates the entry of SARS-CoV-2 into cells in a similar way as for severe acute respiratory syndrome coronavirus (SARS-CoV). The high binding affinity of SARS-CoV-2 to ACE2 correlates with its efficient spread among humans. On the other hand, ACE2 negatively regulates the renin-angiotensin-aldosterone system (RAAS) primarily by converting angiotensin II to angiotensin 1–7, which exerts a beneficial effect on coronavirus-induced acute lung injury. Human recombinant ACE2 has been considered as a potential therapy for SARS-CoV-2 by blocking virus entry and redressing the imbalance of RAAS in SARS-CoV-2 infection. The level of ACE2 expression can be upregulated by treatment with an ACE inhibitor (ACEI) or angiotensin Ⅱ type 1 receptor blocker (ARB). To date, no evidence shows that ACEIs or ARBs increase the susceptibility and mortality of patients infected with SARS-CoV-2, and hence, it is not advisable to discontinue such drugs in patients with cardiovascular disease.
format article
author Meng-Yuan Liu
Bo Zheng
Yan Zhang
Jian-Ping Li
author_facet Meng-Yuan Liu
Bo Zheng
Yan Zhang
Jian-Ping Li
author_sort Meng-Yuan Liu
title Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
title_short Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
title_full Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
title_fullStr Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
title_full_unstemmed Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
title_sort role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
publisher KeAi Communications Co., Ltd.
publishDate 2020
url https://doaj.org/article/206b816da909444199c0f4f7c34d5205
work_keys_str_mv AT mengyuanliu roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019
AT bozheng roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019
AT yanzhang roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019
AT jianpingli roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019
_version_ 1718385258590633984